Shifting from inpatient to outpatient treatment of deep vein thrombosis in a tertiary care center: a cost‐minimization analysis

M Boucher, M Rodger, JA Johnson… - … : The Journal of …, 2003 - Wiley Online Library
Study Objective. To compare the cost of contemporary outpatient and historical inpatient
management of proximal lower limb deep vein thrombosis (DVT) in adults. Design …

The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy

MA Rodger, C Gagné-Rodger, HE Howley, M Carrier… - Thrombosis research, 2003 - Elsevier
Background: The outpatient treatment of deep vein thrombosis (DVT) with low-molecular-
weight heparin (LMWH) has been shown to be cost-effective from the perspective of a third …

Outpatient deep vein thrombosis treatment models.

WA Leong - Pharmacotherapy, 1998 - europepmc.org
Approximately 9000 patients are admitted annually to Canadian hospitals with a primary
diagnosis of deep vein thrombosis (DVT). Although this is a serious medical condition …

Patient outcomes and cost analysis associated with an outpatient deep venous thrombosis treatment program.

JB Groce 3rd - Pharmacotherapy, 1998 - europepmc.org
Low-molecular-weight heparins are safe and effective for outpatient treatment of deep vein
thrombosis (DVT). An outpatient DVT treatment program was established in a 532-bed …

Direct medical cost of managing deep vein thrombosis according to the occurrence of complications

JA O'Brien, JJ Caro - Pharmacoeconomics, 2002 - Springer
Background: Management of deep vein thrombosis (DVT) has evolved from hospitalisation
for intravenous heparin therapy to treatment options that include acute management as an …

Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis–an economic evaluation

AGM van den Belt, PMM Bossuyt… - Thrombosis and …, 1998 - thieme-connect.com
Two clinical trials in patients with acute deep venous thrombosis have indicated that the
outpatient management with fixed-dose, subcutaneous low-molecular-weight heparin is at …

Cost savings and effectiveness of outpatient treatment with low molecular weight heparin of deep vein thrombosis in a community hospital

M Lee, D Pao, T Hsu, A Sonderskov - Journal of Population …, 2004 - jptcp.com
This study was conducted at Centenary Health Centre of the Rouge Valley Health System, a
community based hospital in Toronto. In January 1997, a new treatment was introduced for …

Issues in developing an outpatient deep venous thrombosis treatment program: university hospital experience.

P Yurkowski - Pharmacotherapy, 1998 - europepmc.org
Low-molecular-weight heparins (LMWHs) are safe and effective in the treatment of venous
thromboembolic disease. Since they require less therapeutic monitoring than unfractionated …

Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis-An economic evaluation

AGM Von Den Belt, PMM Bossuyt… - Thrombosis and …, 1998 - researchnow.flinders.edu.au
Two clinical trials in patients with acute deep venous thrombosis have indicated that the
outpatient management with fixed-dose, subcutaneous low-molecular-weight heparin is at …

Home treatment of deep vein thrombosis: an out-patient treatment model with once-daily injection of low-molecular-weight heparin (tinzaparin) in 555 patients

L Lapidus, J Börretzen, M Fahlén… - … of haemostasis and …, 2002 - karger.com
Abstract During a 22-month period, 555 consecutive patients at seven hospitals in the
western part of Sweden with an acute deep vein thrombosis (DVT) not involving the iliac …